Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials

David DeWorsop(Yale University), Deepak Cyril D’Souza(Yale University), Mohini Ranganathan(Yale University), Jasra Ali Bhat(Yale University), Halle Thurnauer(Yale University), Gina Creatura(Temple University), Kimberlee Forselius-Bielen(Yale University), Grai Bluez(Yale University), Emma Deaso(Yale University)

Drug and Alcohol Dependence

March 25, 2016

10.1016/j.drugalcdep.2016.02.045

Cited by 27

Related Papers

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

|Psychopharmacology|2018|235

Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis

|Biological Psychiatry Cognitive Neuroscience and Neuroimaging|2015|210

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder

|JAMA|2022|195

Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial

|The Lancet Psychiatry|2018|194

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment

|JAMA|2017|156